Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized Controlled Trial of Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Recurrent or Persistent Nasopharyngeal Carcinoma

NCT01086488 is registered in ClinicalTrials.gov with Ministry of Health, Malaysia as lead sponsor.

NCT NCT01086488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01086488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized Controlled Trial of Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Recurrent or Persistent Nasopharyngeal Carcinoma
Lead sponsor
Ministry of Health, Malaysia
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2009
Completion date
October 31, 2011
Enrollment
66 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma